Showing 2601-2610 of 5771 results for "".
- 2019 American Academy of Optometry Resident Travel Fellowship Recipients Announcedhttps://modernod.com/news/2019-american-academy-of-optometry-resident-travel-fellowship-recipients-announced/2476868/The American Academy of Optometry named the recipients of the 2019 Resident Travel Fellowship Awards. These travel fellowships will allow residents to attend Academy 2019 Orlando and 3rd World Congress of Optometry, October 23-27, 2019. Allergan Resident
- Glaukos Announces Agreement to Buy Avedro in All-Stock Dealhttps://modernod.com/news/glaukos-announces-agreement-to-buy-avedro-in-all-stock-deal/2479551/In a move to diversify its offerings and expand its corneal health franchise, Glaukos agreed to acquire cross-linking company Avedro in an all-stock transaction.
- Wills Eye Takes Top Honors For ‘Excellence In Patient Care’ In Annual Best Hospitals’ Listhttps://modernod.com/news/wills-eye-takes-top-honors-for-excellence-in-patient-care-in-annual-best-hospitals-list/2476781/In the 2019-2020 U.S. News & World Report Best Hospitals Rankings, board certified physicians throughout the U.S. voted Wills Eye a top center of excellence where they would refer their most complex patients. “The news of this peer recognition is tremendously gratifying an
- Prism Vision Group Announces Launch of New Brandhttps://modernod.com/news/prism-vision-group-announces-launch-of-new-brand/2476726/Prism Vision Group, an ophthalmology administrative services care provider organization, was officially launched. The new entity is led by Steven Madreperla, MD, PhD, a practicing ophthalmologist and one of the founding partners of NJRetina, a specialty retina practice with roots that reac
- Biotech Healthcare Announces Korean Good and Manufacturing Practices Approvalhttps://modernod.com/news/biotech-healthcare-announces-korean-good-and-manufacturing-practices-approval/2476544/Biotech Healthcare has received KGMP (Korean Goods & Manufacturing Practice) approval, allowing its ophthalmic products to be accessible to South Korean markets. “Today when we talk about addressing the urgent need of global eye care problems, may that be cataracts or the myopic wave t
- Academy 2019 Orlando and 3rd World Congress of Optometry Education Program Announcedhttps://modernod.com/news/academy-2019-orlando-and-3rd-world-congress-of-optometry-education-program-announced/2476458/The World Council of Optometry and the American Academy of Optometry have partnered to present an impressive education program taking place at Academy 2019 Orlando and the 3rd World Congress of Optometry, October 23 to 27, 2019. This joint meeting will bring global optometry together t
- Allergan to Present New Data on Bimatoprost SR at the American Glaucoma Society Annual Meetinghttps://modernod.com/news/allergan-to-present-new-data-on-bimatoprost-sr-at-the-american-glaucoma-society-annual-meeting/2476377/Allergan will present new data, including a late-breaking abstract, for Bimatoprost SR at the American Glaucoma Society (AGS) meeting in San Francisco. The abstract, to be presented for the first time on March 16, is
- The American Optometric Association Highlights the Importance of Early Intervention through Annual Eye Examshttps://modernod.com/news/the-american-optometric-association-highlights-the-importance-of-early-intervention-through-annual-eye-exams/2479593/More than 40 percent of Americans are myopic and that number is increasing at an alarming rate, especially among school-aged children. In fact, one in four parents have a child with myopia, and about three quarters of children with myopia were diagnosed between the ages of 3 and 12, according to
- EyeQue Announces Availability of PDCheck on Kickstarter Websitehttps://modernod.com/news/eyeque-announces-availability-of-pdcheck-on-kickstarter-website/2476210/EyeQue, which develops at-home vision tests for smartphones, said this week that its PDCheck tool, a method for measuring pupillary distance (PD), is now available on Kickstarter, according to a
- Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with DMEhttps://modernod.com/news/kodiak-sciences-announces-completion-of-12-week-phase-1a-study-of-ksi-301-in-patients-with-diabetic-macular-edema/2476243/Kodiak Sciences reported 12-week data from its phase 1a single ascending dose clinical study of KSI-301, an investigational anti-VEGF antibody biopolymer conjugate, in nine patients with severe diabetic macular edema. After a single dose, eight of nine patients responded to KSI-301, as ass